Global Pharmatech, Inc. engages in the discovery, development, manufacture, and marketing of proprietary drugs developed based on traditional Chinese medicine. The company is headquartered in Changchun, Jilin and currently employs 217 full-time employees. The company went IPO on 2006-05-12. The Company’s main patented products include JUTAI SOFT CAPSULE, QINGXUAN ANTI-HYPERTENSION TABLET, YANREQING TABLET. The firm is also engaged in the manufacture and sales of other proprietary drugs, generics and dietary supplements used to treat symptoms ranging from headaches, coughing and dry mouth to infections and numbness of limbs. The firm also engages in the provision of biotechnology services, including research and development, testing, manufacturing drugs in liquid and solid dose forms, sales and marketing. The firm conducts its business in the domestic and overseas markets.
Follow-Up Questions
GBLP 주식의 가격 성능은 어떻습니까?
GBLP의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
Global Pharmatech Inc의 주요 사업 주제나 업종은 무엇입니까?
Global Pharmatech Inc은 Consumer products 업종에 속하며, 해당 부문은 Consumer Staples입니다
